![Ola Melin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ola Melin
Geschäftsführer bei
CIRCIO HOLDING ASA
Profil
Ola Melin is currently the Chief Operating Officer at Circio Holding ASA. Prior to this role, she worked as the Director of Technical Operations at OxThera AB and as the Director of Extended Manufacturing at Swedish Orphan Biovitrum AB. Ms. Melin completed her undergraduate degree at Mälardalen University.
Aktive Positionen von Ola Melin
| Unternehmen | Position | Beginn |
|---|---|---|
| CIRCIO HOLDING ASA | Geschäftsführer | - |
Ehemalige bekannte Positionen von Ola Melin
| Unternehmen | Position | Ende |
|---|---|---|
OxThera AB
 OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Technik-/Wissenschafts-/F&E-Leiter | - |
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - |
Ausbildung von Ola Melin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
15
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
OxThera AB
OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Health Services |
Mälardalen University
 Mälardalen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
